How Much Did PEPID Raise?
Funding & Key Investors

PEPID has solidified its market position through a series of significant capital injections, culminating in a total funding accumulation of $656K. The most recent strategic investment of $306K underscores the firm's ongoing commitment to scaling its clinical decision support infrastructure. By securing this substantial financing, the organization is well-positioned to expand its reach within the competitive healthcare technology landscape, ensuring that its medical reference resources remain at the forefront of clinical practice.

What is PEPID?

PEPID
SoftwareHealthcare Software

Established in 1994, PEPID operates as a critical provider of clinical decision support tools and medical reference resources. The company serves a diverse ecosystem of healthcare professionals, including emergency physicians, primary care practitioners, and medical students. Its platform is engineered to enhance diagnostic accuracy and treatment efficacy by providing integrated, peer-reviewed drug information and medical content. Through its long-standing history of innovation, PEPID has become an essential partner for hospitals and educational institutions seeking to optimize patient outcomes through data-driven decision-making. The company's core competencies lie in the seamless integration of complex medical data into the clinical workflow, effectively bridging the gap between research and bedside application.

How much funding has PEPID raised?

PEPID has raised a total of $656K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$306K

Debt (2020): $350K with participation from PPP

Debt (2021): $306K led by PPP

Key Investors in PEPID

PPP

Public-Private Partnership

Undisclosed Investor

A private capital partner participating in the latest financing round to support the company's long-term operational objectives.

Undisclosed Investor

A strategic financial entity providing debt financing to facilitate the scaling of clinical decision support platforms.

What's next for PEPID?

With the recent infusion of capital, PEPID is poised to accelerate its product development roadmap and deepen its penetration into enterprise-level healthcare markets. The strategic focus will likely center on enhancing the interoperability of its platform with existing electronic health record systems, thereby increasing the utility of its medical content for large-scale hospital networks. As the demand for real-time, evidence-based clinical guidance continues to rise, PEPID is strategically aligned to leverage its historical expertise to capture additional market share. Future growth initiatives will likely prioritize the expansion of its digital footprint and the integration of advanced analytics to further empower healthcare providers in high-pressure clinical environments.

See full PEPID company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftwareAuctionsRetailMobile App Development
Customer Engagement PlatformsSoftwareColleges & UniversitiesEducation
Engineering SoftwareSoftwareEnterprise Resource Planning (ERP)
Customer Engagement PlatformsSoftware

Frequently Asked Questions Regarding PEPID Financial Insights

What are the most recent funding rounds that PEPID has completed, and what were the funding rounds?
PEPID has recently completed 2 funding rounds: Debt on Jan 20, 2021, Debt on Apr 8, 2020.
What is the total amount of funding PEPID has raised to date?
PEPID has raised a total of $656K in funding to date.
How many funding rounds has PEPID completed?
PEPID has completed 2 funding rounds.
How much funding did PEPID raise in its most recent funding round?
PEPID raised $306K in its most recent funding round.
Who are the lead investors in PEPID's latest funding round?
The lead investor in PEPID's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PEPID's history?
The largest funding round in PEPID's history was $350K.
See more information about PEPID